Cold Chain Advantage Markets for cold chain free reagents reduce logistics complexity and costs, expanding potential customers in global R&D and manufacturing. Position SBT to partner with distributors, contract manufacturers, and biotech firms seeking robust reagent supply without cold-chain constraints.

End-to-End Platform SBT’s platform combines bioinformatics, expression, and in vitro production to deliver antibody reagents quickly. This end-to-end capability creates opportunities for licensing, co-development, or contracted R&D services that plug directly into client workflows.

Stability Focus Focused on designing scFvs for stability and production efficiency, SBT can support formulation, stability testing, and scale-up efforts to improve shelf life and manufacturability.

Lean Engagement With a lean team and solid revenue, there is appetite for outsourced or flexible engagement models such as CRO services, bioinformatics support, and license-based access to core platform to accelerate customer projects.

Regional Ties Located in Madison, WI, SBT is well positioned to partner with local universities and biotech clusters for research collaborations, sponsored projects, and joint ventures.